Abstract: In our present invention, we propose soluble nanoparticles formed from core compounds (water-insoluble hydrophilic) or hydrophilic compounds and amphiphilic polymers, which establish solubility and/or extended stability. The hydrophilic compounds in soluble nanoparticles ("Solunanoparticles") can also be composed of pharmaceutical compounds, food additives, cosmetics, agricultural products, and veterinary products. The present invention also provides a new strategy for the preparation of soluble nano-sized particles and a new chemical reactor for the production of complex inclusions containing soluble nano-sized particles.
A hybrid material is understood to be a material in which the organic phase (polymer) and inorganic (e.g., oxide) are mixed at the molecular level and corresponds to a compound with a high homogeneity, where the inorganic phase is often obtained in-situ from inorganic precursors through a sol-gel process. A nanocomposite is characterized because the array has scattered discrete structural units. The IUPAC defines a hybrid material as a material composed of an intimate mixture of inorganic components, organic components, or both types of components. Meanwhile, a nanocomposite is defined as a composite in which at least one of the phase domains have at least one dimension on the order of nanometers. Despite these differences, there is an unclear limit of the definitions, and diverse authors use the terms nanocomposite and hybrid interchangeably.
OBJECTIVES OF INVENTION
Polymer matrices of resins can be of synthetic nature or biopolymers. Similarly, to water-soluble polymers, for their use in the area of heavy metal pollutant removal from aqueous sources, the polymer must possess ionizable groups that allow interaction with an ionic species through electrostatic forces or groups capable of forming a chelate establishing coordination bonds with the metal. In these cases, it is usual to use polymers that have groups such as sulfonic acids, carboxylic acids, ammonium, and amine or chelating agents such as iminodiacetic, N-methyl-D-glucamine, amidoxime, aminophosphonic acids, thiourea, and 2-picolylamine. The incorporation of a moiety of different chemical nature into the polymer matrix, such as one with an inorganic nature, can lead to a composite material that can exhibit novel properties and functions. A composite material is a material consisting of two phases of different chemical nature (organic, metal, or ceramic), where the phase in greater proportion is the matrix, and the filler corresponds to that in the lowest proportion. When the filler particles are on a nanometer scale, i.e., between 1 and 100 nm in at least one dimension, the resulting material is referred to as a nanocomposite.
Field of the invention
The enchancment of the loading content material of hydrophilic capsules by means of polymer
nanoparticles (NPs) lately has acquired expanded interest from the area of managed release.
We developed a novel, sincerely modified, drop-wise nanoprecipitation technique which
separated hydrophilic drugs and polymers into aqueous section (continuous phase) ,
f
and natural section (dispersed phase), both individually and involving a mixing process. Using this method, we produced ciprofloxacin-loaded NPs via Poly (d,l-lactic acid)-Dextran (PLA-DEX) and Poly lactic acid-co-glycolic acid-Polyethylene glycol (PLGA-PEG) successfully, with a big drug-loading capability up to 27.2 wt% and an in vitro sustained launch for up to six days.
feed attention of ciprofloxacin. These research advocate that this modified nanoprecipitation approach is a rapid, facile, and reproducible method for making nano-scale drug delivery carriers with excessive drug-loading capabilities.
Background of the Invention
The invention belongs to the field of nanoparticles. More specifically, the present invention relates to soluble nanoparticles ("solunanoparticles") and methods for preparing solunanoparticles that dissolve insoluble compounds in an otherwise insoluble medium. Two major obstacles to effective drug delivery and disease management are solubility and stability. To be absorbed by the body, the compound must dissolve in water and fat (lipid) at the same time. However, water solubility is often related to poor fat solubility and vice versa.
OBJECTIVES OF INVENTION
Solubility and stability problems are the main formulation obstacles hindering the development of therapeutic agents. For formulations with complex organic structures found in pharmaceuticals, water solubility is a necessary but often elusive property. The traditional formulation system for extremely poorly soluble drugs involves a combination of organic solvents, surfactants, and extreme pH conditions. These preparations are often irritating to patients and can cause adverse reactions. Sometimes these methods are not enough to dissolve sufficient amounts of drugs for parenteral preparations. In this case, doctors may1 appreciate "overdose", such as the use of poorly soluble vitamins. In most cases, this overdose will not cause any harm, because the unabsorbed amount will be excreted in the urine. , However, excessive amounts will waste a large amount of active compound. The size of the carrier molecule also plays an important role in its solubility, stability and bioavailability.
Bioavailability refers to the extent to which a drug can be used to target tissues or replace any
targets in the body (ie, receptors, tumors, etc.) after being administered to the body. Poor^
bioavailability is a major problem encountered in the development of pharmaceutical
compositions, especially those containing active ingredients that are hardly soluble in water.
Insoluble droplets are often eliminated from the gastrointestinal tract before being absorbed
into the circulation. As we all know, the dissolution rate of granular drugs will increase with the
increase of surface area, that is, with the decrease of particle size. Recently, interest in
nanotechnology and nanoscale operations has surged. Nanotechnology is not a new field. The
colloidal sol and the supported platinum catalyst are nanoparticles. However, recent interest in
the nanoscale has produced materials for entrainment and transport entrainment.
Principal of Technology:
The goal of this learn about was once to recognize and look at the relationship between |
experimental elements and their responses in the coaching of ciprofloxacin i
hydrochloride based totally stable lipid nanoparticles. A quadratic relationship used to ,
be studied with the aid of growing central composite rotatable design. Amount of lipid and
drug, stirring velocity and stirring time had been chosen as L^—^
experimentgijelernents whilst particle size, zeta^a^aj^l^Mevand drug entrapment had fyej^ffuJJ^Ofr
as responses. Prior to the experimental design, a qualitative prescreening find out about used to be performed to take a look at the impact of a variety of stable lipids and their combinations. Results confirmed that altering the quantity of lipid, stirring velocity and stirring time had a important have an impact on on the entrapment efficiencies and particle dimension of the organized stable lipid nanoparticles. The particle dimension of a strong lipid nanoparticle was once in the vary of 159-246 nm and drug encapsulation efficiencies had been marginally extended by using deciding on a binary combination of bodily incompatible stable lipids. Release of ciprofloxacin hydrochloride from strong lipid nanoparticle used to be notably slow, and it indicates Higuchi matrix mannequin as the fine equipped model. Study of strong lipid nanoparticle advised that the lipid primarily based provider machine ought to doubtlessly be exploited as a transport gadget with increased drug entrapment effectivity and managed drug launch for water soluble actives.
Methodology;
Nanoparticles are usually viewed to be solids whose diameter is varies between 1-1000 nm. Although a quantity of solubilization applied sciences do exist, such as liposomes, cylcodextrins, microencapuslation, and dendrimers, every of these applied sciences has a range of sizable disadvantages.
Phospholipids uncovered to aqueous surroundings structure a bi-layer shape referred to as liposomes. Liposomes are microscopic spherical constructions composed of phospholipids that had been first found in the early Nineteen Sixties. In aqueous media, phospholipid molecules, being amphiphilic, spontaneously prepare themselves in self-closed bilayers as a end result of hydrophilic and hydrophobic interactions. The ensuing vesicles, referred to as liposomes, consequently encapsulate in the indoors section of the aqueous medium in which they are suspended, a property that makes them attainable carriers for biologically energetic hydrophilic molecules and capsules in vivo. Hydrophilic dealers may also additionally be transported, embedded in the liposomal membrane. Liposomes resemble the bio-membranes and have been used for many years as a device for solubilization of organic lively molecules insoluble in water. They are non-toxic and biodegradable and can be used for unique goal organs.
Liposome technology allows the use of unilamellar (ULV) and multilamellar (MLV) vesicles to prepare small to large vesicles. MLV is produced by mechanical agitation. Large ULV is produced by MLV by extrusion through a membrane of known pore size under pressure. The diameter of liposomes is usually 200 nm or less, but liposomes can be customized to meet almost any need by changing lipid content, surface changes, and preparation methods. As drug carriers, liposomes have several potential advantages, including the ability to transport large quantities of drugs, relatively easy preparation, and low toxicity when natural lipids are used. However, common problems encountered by liposomes include: low stability, short shelf life, poor tissue specificity, and the toxicity of unnatural lipids.
In addition, the uptake of phagocytes reduces circulation time. In addition, preparing liposome
formulations with narrow size distribution under harsh conditions is a arduous challenge and
high cost. In addition, membrane clogging often occurs during the larger volume production
process required for the drug production of a specific drug. ( ^
Cyclodextrin is^a-oon-reducing, cyclic, watef-sekible crystalline oligosaccharide composemdif
six, seven or eight glucopyranose units, called a, 3, and y cyclodextrins, respectively. They have long been called The complex forms the inclusions of the product. The cyclodextrin backbone provides hollow cone-shaped molecules with a hydrophilic outer surface and a hydrophobic inner cavity. The hydrophilic surface of
produces good water solubility for cyclodextrin, and the hydrophobic cavity provides a favorable environment in which carrier molecules can be surrounded, wrapped or captured. This combination separates the drug from the aqueous solvent and can increase the solubility and stability of the entrainment in water. For a long time, due to limited supply and high prices, most cyclodextrins were nothing more than scientific curiosities.
What is claimed is:
1. Polymer materials have made great progress in the adsorption process used to treat sewage. The purpose of this review is to introduce the latest developments in this research field by examining the research of functional water-soluble polymers and water-soluble polymer-metal complexes coupled with ultrafiltration membranes for liquid-liquid phase purification processes. It is recognized that water-soluble polymers can be converted into insoluble compounds by establishing cross-linking points, linking polymer chains, and forming polymer resins suitable for solid and liquid extraction processes. In addition, these cross-linked polymers can be used to develop more complex systems, such as (nano) compounds and hybrid adsorbents, combining polymers with inorganic parts (such as metal oxides). This combination produces a new type of material that overcomes some of the shortcomings of each individual component and improves adsorption performance. In addition, this review also discusses new trends in hybrid methods combining water-soluble polymers, membranes, and electrocatalytic/photocatalytic removal of inorganic pollutants.
2. Currently, various extraction methods are used to remove contaminants in natural water or wastewater. These methods are mainly based on the two-phase distribution of liquid-liquid extraction, adsorption, precipitation and other methods. Among them, the membrane method and the adsorption method are the most developed, using mainly polymeric materials. There are a variety of water soluble polymers commercially available or obtainable by synthetic routes. In general, functional polymers can be obtained by free radical polymerization or by addition polymerization using techniques that provide greater control over molecular structure, such as atom transfer radical polymerization (ATRP). A functional polymer can be identified as a compound having a functional group (for example, carboxylic acid, hydroxy!, or amino) or a polymer that performs a specific function.
i
3. The combination of water soluble polymers and ultrafiltration membranes, called Liquid
Polymer Based Retention Technology (LPR), can remove metals or metalloid ions from
water sources, which will be described in this review. By establishing cross-linking points,
water-soluble polymers can be converted to insoluble compounds, thereby connecting
polymer chains to form polymer resins. For decades, organic resins have proven to be the
basic material for retaining substances through ion exchange. Some of the advantages are
mechanical and chemical stability, high exchange capacity, and the ability to select groups
ofligands.
| # | Name | Date |
|---|---|---|
| 1 | 202111045404-Correspondence-061021.pdf | 2021-10-19 |
| 1 | 202111045404-Form-9-061021.pdf | 2021-10-19 |
| 2 | 202111045404-Form-1-061021.pdf | 2021-10-19 |
| 2 | 202111045404-Form-5-061021.pdf | 2021-10-19 |
| 3 | 202111045404-Form-2-061021.pdf | 2021-10-19 |
| 3 | 202111045404-Form-3-061021.pdf | 2021-10-19 |
| 4 | 202111045404-Form-2-061021.pdf | 2021-10-19 |
| 4 | 202111045404-Form-3-061021.pdf | 2021-10-19 |
| 5 | 202111045404-Form-1-061021.pdf | 2021-10-19 |
| 5 | 202111045404-Form-5-061021.pdf | 2021-10-19 |
| 6 | 202111045404-Correspondence-061021.pdf | 2021-10-19 |
| 6 | 202111045404-Form-9-061021.pdf | 2021-10-19 |